Rondo Therapeutics
PrivateLast Round
Series A
Mar 2, 2022
Total Funding Raised
$67M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Rondo Therapeutics operates in Healthcare & Life Sciences and is based in Hayward, California. Its latest recorded funding round was a Series A round in March 2022.
Rondo Therapeutics is a biotechnology company that develops bispecific therapeutic antibodies aimed at modulating immune system activation to combat cancer, particularly in solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rondo Therapeutics Comparables
Compare Rondo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Marengo Therapeutics | 82% | |
| Amgen | 75% | |
| Aktis Oncology | 73% |
For institutional investors. Book with your work email.
Rondo Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rondo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Health Investors | Series A |
| Novo Holdings | Series A |
| Canaan Partners | Series A |
| Red Tree Venture Capital | Series A |
| Johnson & Johnson Innovation – JJDC | Series A |
| Johnson & Johnson Innovation - JJDC, Inc. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 62% MoM, reaching 2.8K.
- Jan 1, 2025
Advanced first oncology asset into clinical trials in 2025.
For institutional investors. Book with your work email.
Rondo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rondo Therapeutics's valuation, stock price, and market status.
Is Rondo Therapeutics a public or private company?
Rondo Therapeutics is a private company.
What is the current stock price of Rondo Therapeutics?
Rondo Therapeutics is a private company, so its shares have no public market price. Caplight tracks Rondo Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rondo Therapeutics worth (valuation)?
Valuation information for Rondo Therapeutics is not publicly available.
Can I buy Rondo Therapeutics stock?
Rondo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rondo Therapeutics's last funding round?
Rondo Therapeutics's most recent funding round was Series A on March 2, 2022.
Who are the main investors in Rondo Therapeutics?
Key investors in Rondo Therapeutics include Canaan Partners, Red Tree Venture Capital.
Will Rondo Therapeutics IPO soon?
No public IPO plans have been announced for Rondo Therapeutics.
How can I track Rondo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Rondo Therapeutics's shares on secondary markets.